ABIO logo

ARCA Biopharma (ABIO) Current Assets

Annual Current Assets

$37.43 M
-$5.27 M-12.34%

December 31, 2023

Summary

Performance

1-Year Change

-12.34%

3-Year Change

-25.09%

5-Year Change

+452.32%

15-Year Change

+204.34%

ABIO Current Assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$166.34 M
ABIO annual total current assets is currently -77.50% below its historical high of $166.34 million

3-Year Low

$37.43 M
ABIO annual total current assets is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
ABIO previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

N/A
ABIO next annual earnings announcement has not yet been scheduled

OtherABIObalance sheetmetrics:

Annual Total Assets

$37.86 M
ABIO annual total assets is $37.86 million

Annual Total Liabilities

$841.00 K
ABIO annual total liabilities is $841.00 thousand

Annual Current Liabilities

$637.00 K
ABIO annual total current liabilities is $637.00 thousand

Annual Total Long Term Liabilities

$204.00 K
ABIO annual total long term liabilities is $204.00 thousand

Quarterly Current Assets

$33.82 M
-$2.85 M-7.77%

June 30, 2024

Summary

Performance

3-Month Change

-7.77%

1-Year Change

-10.03%

3-Year Change

-43.32%

5-Year Change

-43.32%

ABIO Quarterly Current Assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$225.60 M
ABIO quarterly total current assets is currently -85.01% below its historical high of $225.60 million

3-Year Low

$33.82 M
ABIO quarterly total current assets is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2024
ABIO previous earnings announcement was published on Jun 30, 2024

Next Quarterly Earnings Report Date

N/A
ABIO next earnings announcement has not yet been scheduled

OtherABIObalance sheetmetrics:

Quarterly Total Assets

$33.84 M
ABIO quarterly total assets is $33.84 million

Quarterly Total Liabilities

$1.27 M
ABIO quarterly total liabilities is $1.27 million

Quarterly Current Liabilities

$1.27 M
ABIO quarterly total current liabilities is $1.27 million

Quarterly Long Term Liabilities

$0.00
ABIO quarterly total long term liabilities is $0.00

Current Assets Formula

Current Assets = Cash and Equivalents + Accounts Receivable + Inventory + Prepaid Expenses + Marketable Securities + Other Current Assets

Annual Current Assets

$37.43 M
ABIO annual total current assets is $37.43 million

Annual Cash & Cash Equivalents

$37.43 M
ABIO annual cash & cash equivalents is $37.43 million

Annual Accounts Receivable

-
ABIO annual accounts receivable value is unknown

Annual Inventory

-
ABIO annual inventory value is unknown

ABIO Current Assets Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-12.3%-10.0%
3 y3 years-25.1%-43.3%
5 y5 years+452.3%-43.3%

ABIO Current Assets Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-31.2%at low-37.9%at low
5 y5-year-31.2%-77.3%-50.8%-78.2%
alltimeall time-77.5%-91.9%-85.0%-91.0%

ARCA Biopharma Current Assets History

DateAnnualQuarterly
Jun 2024
-
$33.82 M(-7.8%)
Mar 2024
-
$36.67 M(-2.5%)
Dec 2023
$430.00 K(+11.4%)
$37.59 M(-3.3%)
Sep 2023
-
$38.89 M(-4.6%)
Jun 2023
-
$40.76 M(-2.3%)
Mar 2023
-
$41.70 M(-2.3%)
Dec 2022
$386.00 K(-23.3%)
$42.70 M(-4.2%)
Sep 2022
-
$44.55 M(-6.5%)
Jun 2022
-
$47.66 M(-5.7%)
Mar 2022
-
$50.54 M(-7.1%)
Dec 2021
$503.00 K(+9.1%)
$54.42 M(-8.8%)
Sep 2021
-
$59.67 M(-7.9%)
Jun 2021
-
$64.79 M(-5.7%)
Mar 2021
-
$68.73 M(+37.5%)
Dec 2020
$461.00 K(+723.2%)
$49.97 M(-3.8%)
Sep 2020
-
$51.94 M(+348.8%)
Jun 2020
-
$11.57 M(+56.9%)
Mar 2020
-
$7.38 M(-13.0%)
Dec 2019
$56.00 K(+16.7%)
$8.48 M(-14.4%)
Sep 2019
-
$9.90 M(-4.1%)
Jun 2019
-
$10.32 M(+21.2%)
Mar 2019
-
$8.52 M(+25.7%)
Dec 2018
$48.00 K(-27.3%)
$6.78 M(-19.2%)
Sep 2018
-
$8.39 M(-16.2%)
Jun 2018
-
$10.01 M(-21.3%)
Mar 2018
-
$12.73 M(+3.5%)
Dec 2017
$66.00 K(-97.9%)
$12.30 M(-24.9%)
Sep 2017
-
$16.38 M(-1.7%)
Jun 2017
-
$16.66 M(-16.1%)
Mar 2017
-
$19.85 M(-7.4%)
Dec 2016
$3.18 M(+383.9%)
$21.45 M(-9.8%)
Sep 2016
-
$23.79 M(-11.0%)
Jun 2016
-
$26.73 M(-13.8%)
Mar 2016
-
$31.02 M(-20.3%)
Dec 2015
$658.00 K(+2.2%)
$38.92 M(-6.6%)
Sep 2015
-
$41.69 M(-6.0%)
Jun 2015
-
$44.33 M(+249.7%)
Mar 2015
-
$12.67 M(-18.2%)
Dec 2014
$644.00 K(+305.0%)
$15.49 M(-11.3%)
Sep 2014
-
$17.46 M(-11.3%)
Jun 2014
-
$19.68 M(-9.7%)
Mar 2014
-
$21.80 M(+28.8%)
Dec 2013
$159.00 K(-4.8%)
$16.93 M(-11.0%)
Sep 2013
-
$19.01 M(-8.0%)
Jun 2013
-
$20.66 M(+417.4%)
Mar 2013
-
$3.99 M(+31.1%)
Dec 2012
$167.00 K(-42.4%)
$3.04 M(-6.7%)
Sep 2012
-
$3.27 M(-9.1%)
Jun 2012
-
$3.59 M(-23.6%)
Mar 2012
-
$4.70 M(-24.3%)
Dec 2011
$290.00 K(-70.8%)
$6.21 M(+2.0%)
Sep 2011
-
$6.09 M(-22.2%)
Jun 2011
-
$7.83 M(+43.5%)
Mar 2011
-
$5.46 M(-23.8%)
Dec 2010
$994.00 K
$7.16 M(-17.4%)
DateAnnualQuarterly
Sep 2010
-
$8.67 M(-19.6%)
Jun 2010
-
$10.78 M(-13.1%)
Mar 2010
-
$12.40 M(+55.9%)
Dec 2009
$1.41 M(+0.9%)
$7.96 M(-30.5%)
Sep 2009
-
$11.45 M(-54.7%)
Jun 2009
-
$25.27 M(-31.6%)
Mar 2009
-
$36.94 M(+281.7%)
Dec 2008
$1.40 M(-93.2%)
$9.68 M(-84.1%)
Sep 2008
-
$60.92 M(-15.4%)
Jun 2008
-
$71.98 M(-13.8%)
Mar 2008
-
$83.46 M(-16.5%)
Dec 2007
$20.70 M(+14.5%)
$99.99 M(-12.4%)
Sep 2007
-
$114.14 M(-17.9%)
Jun 2007
-
$138.95 M(-1.7%)
Mar 2007
-
$141.41 M(-15.0%)
Dec 2006
$18.07 M(-18.9%)
$166.34 M(-12.1%)
Sep 2006
-
$189.24 M(-9.4%)
Jun 2006
-
$208.78 M(-7.5%)
Mar 2006
-
$225.60 M(+163.0%)
Dec 2005
$22.28 M(+67.9%)
$85.77 M(-5.5%)
Sep 2005
-
$90.78 M(-14.3%)
Jun 2005
-
$105.87 M(-12.7%)
Mar 2005
-
$121.28 M(+83.8%)
Dec 2004
$13.27 M(-26.1%)
$66.00 M(-22.9%)
Sep 2004
-
$85.60 M(-7.5%)
Jun 2004
-
$92.50 M(-10.0%)
Mar 2004
-
$102.78 M(+157.9%)
Dec 2003
$17.95 M(-15.3%)
$39.86 M(+65.5%)
Sep 2003
-
$24.09 M(-17.8%)
Jun 2003
-
$29.29 M(-35.0%)
Mar 2003
-
$45.09 M(+666.6%)
Dec 2002
$21.19 M(-10.2%)
$5.88 M(-51.0%)
Sep 2002
-
$12.01 M(-19.3%)
Jun 2002
-
$14.89 M(+57.4%)
Mar 2002
-
$9.46 M(-42.0%)
Dec 2001
$23.60 M(+50.7%)
$16.30 M(-19.8%)
Sep 2001
-
$20.33 M(+94.8%)
Jun 2001
-
$10.43 M(-42.5%)
Mar 2001
-
$18.14 M(+222.3%)
Dec 2000
$15.66 M(+26.3%)
$5.63 M(-64.7%)
Sep 2000
-
$15.96 M(-35.2%)
Jun 2000
-
$24.64 M(-22.9%)
Mar 2000
-
$31.95 M(-3.2%)
Dec 1999
$12.40 M(+27.8%)
$33.00 M(-0.9%)
Sep 1999
-
$33.30 M(-9.5%)
Jun 1999
-
$36.80 M(-13.0%)
Mar 1999
-
$42.30 M(-12.2%)
Dec 1998
$9.70 M(+42.6%)
$48.20 M(+4.1%)
Sep 1998
-
$46.30 M(-12.3%)
Jun 1998
-
$52.80 M(-6.7%)
Mar 1998
-
$56.60 M(-6.0%)
Dec 1997
$6.80 M(+209.1%)
$60.20 M(-7.7%)
Sep 1997
-
$65.20 M(+352.8%)
Jun 1997
-
$14.40 M(+171.7%)
Mar 1997
-
$5.30 M
Dec 1996
$2.20 M
-

FAQ

  • What is ARCA biopharma annual total current assets?
  • What is the all time high annual current assets for ARCA biopharma?
  • What is ARCA biopharma annual current assets year-on-year change?
  • What is ARCA biopharma quarterly total current assets?
  • What is the all time high quarterly current assets for ARCA biopharma?
  • What is ARCA biopharma quarterly current assets year-on-year change?

What is ARCA biopharma annual total current assets?

The current annual current assets of ABIO is $37.43 M

What is the all time high annual current assets for ARCA biopharma?

ARCA biopharma all-time high annual total current assets is $166.34 M

What is ARCA biopharma annual current assets year-on-year change?

Over the past year, ABIO annual total current assets has changed by -$5.27 M (-12.34%)

What is ARCA biopharma quarterly total current assets?

The current quarterly current assets of ABIO is $33.82 M

What is the all time high quarterly current assets for ARCA biopharma?

ARCA biopharma all-time high quarterly total current assets is $225.60 M

What is ARCA biopharma quarterly current assets year-on-year change?

Over the past year, ABIO quarterly total current assets has changed by -$3.77 M (-10.03%)